| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 50.45T | 48.04T | 45.10T | 37.15T | 31.38T | 27.21T |
| Gross Profit | 8.89T | 9.58T | 9.37T | 6.31T | 5.97T | 4.83T |
| EBITDA | 7.27T | 8.27T | 8.39T | 5.19T | 5.30T | 4.27T |
| Net Income | 3.70T | 4.77T | 4.94T | 2.45T | 2.85T | 2.25T |
Balance Sheet | ||||||
| Total Assets | 10.00T> | 93.60T | 90.11T | 74.30T | 67.69T | 62.27T |
| Cash, Cash Equivalents and Short-Term Investments | 7.92T | 15.92T | 14.11T | 9.23T | 8.62T | 9.32T |
| Total Debt | 42.13T | 38.79T | 36.56T | 29.38T | 26.50T | 25.66T |
| Total Liabilities | 62.35T | 56.72T | 54.87T | 45.04T | 40.53T | 37.98T |
| Stockholders Equity | 38.97T | 35.92T | 34.22T | 28.34T | 26.25T | 23.40T |
Cash Flow | ||||||
| Free Cash Flow | 334.81B | -1.21T | -842.02B | -750.76B | -107.63B | -1.04T |
| Operating Cash Flow | 4.64T | 3.70T | 4.21T | 2.96T | 3.72T | 2.73T |
| Investing Cash Flow | -5.02T | -4.19T | -5.00T | -1.60T | -577.50B | -4.68T |
| Financing Cash Flow | -5.76B | 197.24B | 2.50T | -56.18B | -2.47T | 2.74T |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥3.43T | 9.91 | 13.26% | 1.85% | 4.26% | 7.71% | |
68 Neutral | ¥39.10T | 8.70 | 12.89% | 2.78% | 7.92% | -26.12% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
58 Neutral | ¥1.69T | -82.83 | 9.73% | 3.61% | -1.57% | -73.96% | |
56 Neutral | ¥4.91T | 9.73 | 4.09% | 4.41% | -1.94% | -43.84% | |
55 Neutral | ¥635.22B | 6.29 | 1.72% | 4.52% | -2.42% | -93.40% | |
47 Neutral | ¥1.22T | -12.05 | -16.69% | ― | -4.66% | -1038.25% |